European Pharmaceutical Review

MAY 29, 2023

Yet in 2021, 100 nanomedicines had been marketed. Nanoparticle HIV vaccine shows potential in trial Nanomedicines generally require aseptic processing. Despite this, only 13 nanomedicines had been approved by the US Food and Drug Administration (FDA) before 2015. Tanzini et al. Significance of Annex 1–2022 for implementing Pharma 4.0

Process Improvement 95

Process Improvement Packaging Drug Development Vaccines 95

Pharmaceutical Technology

DECEMBER 8, 2022

Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies. Tom Lenaerts is head of global process engineering for Datwyler, a leading supplier of parenteral packaging components such as stoppers and plungers. By Datwyler. United Kingdom.

Packaging 98

Packaging Vaccines Communication Drug Development 98

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Packaging 64

Packaging Vaccines 64

Pharmaceutical Technology

NOVEMBER 1, 2022

Darwin is part of a package of projects and initiatives to transform to data-driven medicines regulation.”. In 2021, the EMA adopted a new legal mandate that strengthened its role in dealing with health threats and health crises. Arlett explains that Darwin EU is playing a collaborative role in this goal. Adoption of EHR data systems.

Medical Records 111

Medical Records Packaging Vaccines 111

European Pharmaceutical Review

OCTOBER 17, 2022

Historically, the 50-year-old site produced oral solids, sterile liquids, packaged products and offered retesting services to the Japanese and Asian markets. Sanofi states its work currently focuses on the research and development of vaccines, therapies for immunological, oncological and neurological disorders and medicines for rare diseases.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Packaging Diabetes Pharmaceutical Companies 104

pharmaphorum

NOVEMBER 27, 2022

However, with a 74% increase in pharmaceutical supply chain disruption in 2021 , this approach cannot be sustained for much longer, not only due to the recent pandemic, but to growing geopolitical fragility exacerbating trade disputes and trade routes. Better communication with traceable data.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

PharmaTech

JUNE 11, 2025

Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. Image Credit: © Anne Czichos - stock.adobe.com Simtra BioPharma Solutions, a sterile injectables contract development and manufacturing organization out of Bloomington, Ind.

Dosage 52

Dosage Drug Development Compounding Vaccines 52

European Pharmaceutical Review

MARCH 11, 2024

Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” One case of drug contamination from 2021 was highlighted in the paper. Ahmed et al.

Sterile Compounds 98

Sterile Compounds Compounding Packaging Pharmaceutical Companies 98

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.

Communication 97

Communication Dosage Packaging Vaccines 97

European Pharmaceutical Review

DECEMBER 26, 2023

Advanced inducible systems to better regulate the expression of certain genes will improve the generation of packaging and producer cell clones, giving companies more control over gene expression for improved safety as well as efficiency. Single-use bioprocessing technologies enabling more rapid vaccines production [Internet].

Drug Pricing 98

Drug Pricing Packaging Drug Development Vaccines 98

pharmaphorum

JANUARY 17, 2022

Book on or before 30 th November 2021 to receive £400 off the conference price. SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. With interactive sessions, opportunities to question and learn, this workshop will discuss national IP rights and the trade of COVID 19 vaccines.

Packaging 52

Packaging Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says. Among other things, supply chain optimisation, maintaining access to affordable vaccines, and supporting innovation for unmet clinical needs will be the discussion topics, she adds.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

MARCH 21, 2023

Based on the individual contract, these CMOs manufacture small molecules or biological active pharmaceutical ingredients (APIs), as well as packaging material, and are charged with other related functions. Sharp Packaging Services is producing the solid dose of the drug and packaging it.

Packaging 59

Packaging Vaccines Labelling Communication 59

Fuld & Company Blog

MAY 15, 2023

  This initiative never got off the ground, as Amazon badly underestimated the complexity of the healthcare market, and it was disbanded in 2021. Technology was used to handle costly administration issues. The Resulting Package By 2020, it was clear that One Medical was hitting a positive note with the market, and so it went public.

Health and Personal Care Stores 59

Health and Personal Care Stores Mail-Order Pharmacies Packaging Medication Delivery 59

Quality Matters

JUNE 14, 2023

According to the Pharmaceutical Security Institute, incidents of counterfeiting, illegal diversion and theft of medicines totaled over 5,900 in 2021. Lessons learned aid preparedness During the COVID-19 pandemic, many distributors were able to quickly pivot to meet unique vaccine storage and temperature requirements.

Dosage 52

Dosage Packaging Documentation Hospitals 52

PharmaShots

APRIL 25, 2023

In Jun 2021, Horizon Therapeutics entered into a global collaboration and license agreement with Arrowhead Pharmaceuticals for ARO-XDH as a treatment for patients with uncontrolled gout. In Nov 2021, GSK entered into a license agreement with Arrowhead to develop and commercialize Arrowhead’s RNAi therapy, ARO-HSD.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

PharmaShots

MARCH 9, 2023

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. Other Affiliations: She is a fellow of the Royal Society (May 2021) associated with Merck.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

pharmaphorum

DECEMBER 13, 2021

It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. There are multiple other mRNA vaccines that are being developed.

Vaccines 105

Vaccines Packaging 105

Pharmaceutical Technology

DECEMBER 15, 2022

The Singapore Government has launched Biologics Pharma Innovation Programme Singapore (BioPIPS), which aims to increase the country’s manufacturing capacity for biologics, including recombinant proteins and vaccines. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Additionally, Merck & Co.

Vaccines 105

Vaccines Packaging Communication Pharmaceutical Companies 105

PharmaTech

JUNE 6, 2025

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. International Biopharmaceutical Industry, 2021 4, 10-13. 2022 11, 41-44 Greer, F and Easton, R.L.

Dosage 52

Dosage Drug Development Documentation Biosimilars 52

Quality Matters

APRIL 20, 2023

Quality across the product lifecycle The role of standards goes far beyond the drug manufacturing process – from the sourcing of raw materials to packaging, labeling, distribution, and point-of-care administration – to help ensure quality across the pharmaceutical product lifecycle.

Biosimilars 52

Biosimilars Labelling Vaccines Generic Medicine 52

FDA Law Blog: Biosimilars

SEPTEMBER 30, 2024

Another rejected proposal was a definition of “vaccine” (vaccines are exempt from Medicaid rebates), which would have limited this term to a product that is administered prophylactically – i.e., to prevent rather than treat a disease. that is not supported by the statute and applicable regulations.”

Vaccines 59

Vaccines Inpatient Packaging Documentation 59

Pharmaceutical Technology

DECEMBER 9, 2022

In 2021 the company also acquired Boston-based Chemic Laboratories, which provides contract analytical, API synthesis, and formulation development. Solvias has extensive experience with analytical method development and testing for mRNA-based vaccines as well as monograph testing of excipients and APIs according to Ph Eur or USP.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

pharmaphorum

JUNE 11, 2021

Ocugen is the first company to be affected by the FDA’s recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of its vaccine candidate. — FDA Biologics (@FDACBER) May 25, 2021. That includes the more transmissible B.1.617.2

Vaccines 83

Vaccines Packaging 83

Pharmaceutical Technology

JULY 14, 2022

Pharmaceutical companies regularly outsource different steps of drug manufacturing processes like parenteral manufacturing and packaging, solid dose, and small molecule or biologic active pharmaceutical ingredient (API) production, among others. Covid-19 vaccines stay in the spotlight.

Vaccines 52

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

SEPTEMBER 14, 2023

It also bears extra replacement expenses when drugs are discarded due to improper packaging. One of the most common use cases is Internet of Things (IoT) sensors placed on containers and packaging to track humidity and temperature in real-time.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Dosage 52

pharmaphorum

JUNE 17, 2022

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing who are also at high risk for progression to severe COVID-19.” .

Hospitals 105

Hospitals Vaccines Packaging 105

Quality Matters

OCTOBER 13, 2021

There are also related standards that address a wide range of topics such as packaging, storage and distribution of medicines, the preparation of compounded medicines and prescription labeling. josh.levin@usp.org Wed, 10/13/2021 - 13:07 Supply Chain

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

Pharmacy Friday Pearls

MARCH 4, 2022

1 risk factor for progression to severe disease a No prior COVID-19 vaccine or infectionStandard of care treatment allowed but primary analysis population was limited to subjects who did NOT receive COVID-19 monoclonal antibodies COVID-19 related hospitalizations/death through day 28: 0.8% Published December 14, 2021. Paxlovid vs. 6.3%

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunity 40

Pharmaceutical Technology

AUGUST 30, 2022

Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Oswaldo Cruz Foundation will package the drug in its facility in Rio de Janeiro before supplying it to the Brazilian public health system; the company is also involved in clinical trials for the drug’s possible use as Covid-19 prophylaxis.

Vaccines 78

Vaccines Pharmaceutical Manufacturing Packaging 78

RX Note

APRIL 21, 2023

Management Based on Disease Severity Regardless of vaccination status, COVID-19 positive cases must quarantine for 7 days from the day they received the positive test result. for all of KL from May 7, 5 May 2021 180k Sinovac vaccine doses bottled by Pharmaniaga to be ready this week, 10 May 2021 Nationwide MCO 3.0

Vaccines 40

Vaccines Health and Personal Care Stores Hospitals Packaging 40

RX Note

FEBRUARY 23, 2023

Figures - Elemental iron and calcium content?

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

pharmaphorum

JANUARY 21, 2021

Those steps were followed in October with a new global policy that banned any adverts that would discourage people from getting vaccinated, whether for COVID, the flu or anything else. “We Meanwhile, Google started this year with the launch of a $3 million fund to tackle misinformation about COVID-19 vaccines. Pharma’s chance to help.

Vaccines 111

Vaccines Packaging 111